Jon Arnason
Impact in
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
- Virus-based gene therapy research
- Immunology top 2%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immunodeficiency and Autoimmune Disorders
Papers in
- Oncology 60
- CAR-T cell therapy research 53
- Immunology 48
- Immunodeficiency and Autoimmune Disorders 16
- Biosimilars and Bioanalytical Methods 15
- Immunotherapy and Immune Responses 7
- Co-authors
- Tim Sparwasser (2 shared papers)Jeremy S. Abramson (37 shared papers)Gérard Eberl (1 shared paper)Hermann Wagner (1 shared paper)Katharina Lahl (1 shared paper)Jennifer Freyer (1 shared paper)Alf Hamann (1 shared paper)Christoph Loddenkemper (1 shared paper)
- Journals
- Blood (56 papers)Journal of Clinical Oncology (12 papers)Blood Advances (5 papers)British Journal of Haematology (4 papers)Transplantation and Cellular Therapy (4 papers)
- Partner nations
- United StatesGermanyIsrael
In The Last Decade
Jon Arnason
112 papers receiving 3.2k citations
Jon Arnason's Hit Papers
Peers
Comparison fields: 5 of 93
- Genetics 756
- Immunology 1.4k
- Oncology 1.6k
- Pathology and Forensic Medicine 988
- Hematology 514
Countries citing papers authored by Jon Arnason
This map shows the geographic impact of Jon Arnason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Arnason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Arnason more than expected).
Fields of papers citing papers by Jon Arnason
This network shows the impact of papers produced by Jon Arnason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Arnason. The network helps show where Jon Arnason may publish in the future.
Co-authors
The 25 scholars most cited alongside Jon Arnason, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease Hit paper breakdown → | 2007 | 722 |
| 2 | 2016 | 227 | |
| 3 | Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study Hit paper breakdown → | 2022 | 186 |
| 4 | 2012 | 132 | |
| 5 | 2018 | 131 | |
| 6 | 2015 | 99 | |
| 7 | 2018 | 90 | |
| 8 | 2019 | 89 | |
| 9 | 2020 | 88 | |
| 10 | 2021 | 84 | |
| 11 | 2021 | 70 | |
| 12 | 2001 | 69 | |
| 13 | 2023 | 68 | |
| 14 | 2021 | 68 | |
| 15 | 2015 | 55 | |
| 16 | 2017 | 54 | |
| 17 | 2020 | 47 | |
| 18 | 2013 | 41 | |
| 19 | 2023 | 41 | |
| 20 | 2021 | 40 |
About Jon Arnason
Jon Arnason is a scholar working on Oncology, Immunology, Genetics, Pathology and Forensic Medicine and Hematology, having authored 120 papers that have together received 3.2k indexed citations. Recurring topics across this work include CAR-T cell therapy research (53 papers), Chronic Lymphocytic Leukemia Research (39 papers), Lymphoma Diagnosis and Treatment (34 papers), Immunodeficiency and Autoimmune Disorders (16 papers), Biosimilars and Bioanalytical Methods (15 papers), Chronic Myeloid Leukemia Treatments (11 papers), Immunotherapy and Immune Responses (7 papers) and Multiple Myeloma Research and Treatments (7 papers). The work is most often cited by research in Genetics (756 citations), Immunology (1.4k citations), Oncology (1.6k citations), Pathology and Forensic Medicine (988 citations) and Hematology (514 citations). Jon Arnason has collaborated with scholars based in United States, Germany and Israel. Frequent co-authors include Tim Sparwasser, Jeremy S. Abramson, Gérard Eberl, Hermann Wagner, Katharina Lahl, Jennifer Freyer, Alf Hamann, Christoph Loddenkemper, Jochen Huehn and Matthew A. Lunning. Their work appears in journals such as Blood, Journal of Clinical Oncology, Blood Advances, British Journal of Haematology and Transplantation and Cellular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.